Diadema Partners »

Catalyst Pharmaceutical Partners shares owned by Diadema Partners

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $985k 50k 19.70

More positions owned by Diadema Partners

Jazz Pharmaceuticals Shs Usd (JAZZ)
Soleno Therapeutics (SLNO)
Uniqure Nv SHS Put Option (QURE)
Regeneron Pharmaceuticals (REGN)
Viking Therapeutics (VKTX)
Bristol Myers Squibb (BMY)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
BioMarin Pharmaceutical (BMRN)
Avidity Biosciences Ord (RNA)
Agios Pharmaceuticals Call Option (AGIO)
Ultragenyx Pharmaceutical (RARE)
Incyte Corporation Call Option (INCY)
Intellia Therapeutics Call Option (NTLA)
Vaxcyte (PCVX)
Eli Lilly & Co. Put Option (LLY)

View all positions for Diadema Partners

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Deerfield Management Company
Renaissance Technologies
Fundsmith
Morgan Stanley
Geode Capital Management
American Century Companies
Dimensional Fund Advisors
Royce & Associates
Millennium Management
Charles Schwab Investment Management
Arrowstreet Capital, Limited Partnership
Robeco Investment Management

View all funds holding Catalyst Pharmaceutical Partners